The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Beller, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Beller, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
Hazardous Substances DB
*L-TYROSINE
The Journal of Immunology, 2002, 169: 581-586.
Copyright © 2002 by The American Association of Immunologists

Aberrant Production of IL-12 by Macrophages from Several Autoimmune-Prone Mouse Strains Is Characterized by Intrinsic and Unique Patterns of NF-{kappa}B Expression and Binding to the IL-12 p40 Promoter1

Jiajian Liu and David Beller2

Arthritis Section, Department of Medicine, Boston University Medical Center, Boston MA 02118

Intrinsic defects in macrophage (M{phi}) cytokine production characterize many autoimmune-prone mouse strains. Aberrant levels of IL-12, for example, are produced by M{phi} isolated from young mice prone to lupus (MRL and NZB/W) and diabetes (nonobese diabetic (NOD)) well before the appearance of disease signs. Evaluation of the possible mechanism(s) underlying the abnormal regulation of IL-12 in these strains revealed novel patterns of Rel family protein binding to the unique p40 NF-{kappa}B site in the IL-12 p40 promoter, whereas binding patterns to Ets and CCAAT enhancer binding protein/{beta} sites were normal. In particular, the heightened production of IL-12 by NOD M{phi} is associated with elevated levels of the trans-activating p50/c-Rel (p65) complex compared with the nonfunctional p50/p50 dimer. Conversely, the dramatically impaired production of IL-12 by both NZB/W and MRL/+ M{phi} is associated with a predominance of p50/p50 and reduced p50/c-Rel(p65) binding. Mechanistically, the unique pattern seen in the lupus strains reflects elevated p50 and reduced c-Rel nuclear protein levels. In NOD extracts, the level of c-Rel is elevated compared with that in lupus strains, but not when compared with that in normal A/J. However, the extent of c-Rel tyrosine phosphorylation noted in NOD extracts is more than double that seen in any other strain. Levels of p65 were similar in all strains tested. These findings reveal that a common mechanism, involving dysregulation of c-Rel and p50, may be used to determine the aberrant IL-12 levels that have the potential to predispose specific mouse strains to systemic or organ-specific autoimmunity.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. M. Marleau, K. L. Summers, and B. Singh
Differential Contributions of APC Subsets to T Cell Activation in Nonobese Diabetic Mice
J. Immunol., April 15, 2008; 180(8): 5235 - 5249.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Gilbert, D. G. Carnathan, P. C. Cogswell, L. Lin, A. S. Baldwin Jr, and B. J. Vilen
Dendritic Cells from Lupus-Prone Mice Are Defective in Repressing Immunoglobulin Secretion
J. Immunol., April 15, 2007; 178(8): 4803 - 4810.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Saccani, T. Schioppa, C. Porta, S. K. Biswas, M. Nebuloni, L. Vago, B. Bottazzi, M. P. Colombo, A. Mantovani, and A. Sica
p50 Nuclear Factor-{kappa}B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance
Cancer Res., December 1, 2006; 66(23): 11432 - 11440.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Lin and S. L. Peng
Coordination of NF-{kappa}B and NFAT Antagonism by the Forkhead Transcription Factor Foxd1.
J. Immunol., April 15, 2006; 176(8): 4793 - 4803.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. J. Boyton, S. Davies, C. Marden, C. Fantino, C. Reynolds, K. Portugal, H. Dewchand, and D. M. Altmann
Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread
Int. Immunol., September 1, 2005; 17(9): 1157 - 1165.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Falasca, V. Iadevaia, F. Ciccosanti, G. Melino, A. Serafino, and M. Piacentini
Transglutaminase Type II Is a Key Element in the Regulation of the Anti-Inflammatory Response Elicited by Apoptotic Cell Engulfment
J. Immunol., June 1, 2005; 174(11): 7330 - 7340.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. L. Belladonna, M. C. Fioretti, D. V. Serreze, U. Grohmann, and P. Puccetti
CTLA-4-Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
J. Exp. Med., October 18, 2004; 200(8): 1051 - 1062.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Bouma, W. K. Lam-Tse, A. F. Wierenga-Wolf, H. A. Drexhage, and M. A. Versnel
Increased Serum Levels of MRP-8/14 in Type 1 Diabetes Induce an Increased Expression of CD11b and an Enhanced Adhesion of Circulating Monocytes to Fibronectin
Diabetes, August 1, 2004; 53(8): 1979 - 1986.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
Y. Charoenvit, G. T. Brice, D. Bacon, V. Majam, J. Williams, E. Abot, H. Ganeshan, M. Sedegah, D. L. Doolan, D. J. Carucci, et al.
A Small Peptide (CEL-1000) Derived from the {beta}-Chain of the Human Major Histocompatibility Complex Class II Molecule Induces Complete Protection against Malaria in an Antigen-Independent Manner
Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2455 - 2463.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. Lin, M. S. Spoor, A. J. Gerth, S. L. Brody, and S. L. Peng
Modulation of Th1 Activation and Inflammation by the NF-{kappa}B Repressor Foxj1
Science, February 13, 2004; 303(5660): 1017 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
U. Grohmann, F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. C. Fioretti, and P. Puccetti
A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice
J. Exp. Med., July 7, 2003; 198(1): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Liu and D. I. Beller
Distinct Pathways for NF-{kappa}B Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains
J. Immunol., May 1, 2003; 170(9): 4489 - 4496.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. Potter, J. Cortes-Hernandez, P. Quartier, M. Botto, and M. J. Walport
Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells
J. Immunol., March 15, 2003; 170(6): 3223 - 3232.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Sen, S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin Jr., and R. Tisch
NF-{kappa}B Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages
J. Immunol., February 15, 2003; 170(4): 1770 - 1780.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Bouzahzah, S. Jung, and J. Craft
CD4+ T Cells from Lupus-Prone Mice Avoid Antigen-Specific Tolerance Induction In Vivo
J. Immunol., January 15, 2003; 170(2): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Anderson and K. L. Fritsche
(n-3) Fatty Acids and Infectious Disease Resistance
J. Nutr., December 1, 2002; 132(12): 3566 - 3576.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.